跳至主要内容
临床试验/EUCTR2019-002232-82-SE
EUCTR2019-002232-82-SE进行中(未招募)1 期

Downstream targets of SSRI effect in treatment of Major Depressive Disorder

Karolinska Institutet0 个研究点目标入组 20 人开始时间: 2019年6月17日最近更新:
适应症

试验速览

阶段
1 期
状态
进行中(未招募)
入组人数
20

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional clinical trial of medicinal product

入排标准

入选标准

  • age 20-80 years
  • ongoing major depressive episode according to M.I.N.I. interview
  • healthy, apart from MDD, according to MRI, clinical interview, physical examination, blood tests (Hb, ASAT, ALAT, GT, Na, K, creatinine, calcium, albumin, TSH, glucose).
  • Are the trial subjects under 18? no
  • Number of subjects for this age range:
  • F.1.2 Adults (18-64 years) yes
  • F.1.2.1 Number of subjects for this age range 15
  • F.1.3 Elderly (>=65 years) yes
  • F.1.3.1 Number of subjects for this age range 5

排除标准

  • ongoing pharmacological treatment (wash out-time one month, drugs not used for MDD treatment and without serotonergic effect may be allowed at the discretion of the PI)
  • bipolar disorder
  • psychotic syndrome
  • alcohol/drug dependence
  • organic central nervous system disorder
  • patient who is not suitable for MRI (claustrophobia, MRI incompatible metal implants)
  • pregnancy.
  • Allergy or hypersensitivity to escitalopram
  • Ongoing treatment with any medication that is known to prolong the QT interval
  • Ongoing treatment with any monoamine oxidase inhibitor

研究者

相似试验

Downstream targets of SSRI effect in treatment of... | 临床试验